lung
cancer
lead
caus
cancer
death
world
today
pois
claim
approxim
billion
live
centuri
major
challeng
treat
cancer
intrins
resist
convent
therapi
demonstr
stemprogenitor
cell
respons
sustain
growth
surviv
invas
tumor
identifi
stem
cell
lung
cancer
defin
biolog
process
necessari
exist
paramount
develop
new
clinic
approach
goal
prevent
diseas
recurr
review
summar
understand
cellular
molecular
mechan
oper
within
put
canceriniti
cell
core
lung
neoplasia
million
death
per
year
lung
cancer
repres
lead
caus
cancer
mortal
worldwid
thank
larg
doll
hill
semin
paper
public
surgeon
gener
report
longheld
suspicion
connect
tobacco
smoke
lung
cancer
today
readili
acknowledg
predict
approxim
million
death
caus
smoke
annual
year
one
quarter
attribut
lung
cancer
despit
mark
improv
surviv
patient
common
malign
eg
breast
prostat
aris
advanc
diagnost
surgeri
chemotherapi
overal
surviv
rate
lung
cancer
chang
littl
recent
decad
figur
less
develop
countri
unit
state
pictur
even
bleaker
lung
cancer
patient
present
smallcel
lung
cancer
sclc
aggress
malign
nonsmallcel
lung
cancer
nsclc
character
earli
dissemin
despit
initi
sensit
chemotherapi
radiotherapi
overal
surviv
sclc
patient
less
surviv
statist
suggest
recurr
common
among
lung
cancer
patient
often
refractori
firstlin
therapi
initi
employ
treat
diseas
one
approach
improv
outcom
lung
cancer
search
uniqu
phenotyp
defin
cancer
stemcel
popul
cell
one
potenti
sourc
tumor
recurr
might
exhibit
distinct
therapeut
vulner
exploit
way
control
erad
minim
residu
diseas
lung
cancer
cell
long
life
span
like
accru
requisit
number
varieti
genet
alter
necessari
acquir
full
tumorigen
capac
normal
stem
cell
defin
number
characterist
highlight
candidaci
popul
ideal
canceriniti
cell
includ
longev
via
critic
properti
selfrenew
capac
extens
prolifer
via
transitamplifi
daughter
cell
multipot
far
new
concept
cancer
stem
cell
csc
hypothesi
develop
earlier
observ
unlik
normal
adult
tissu
cancer
consist
heterogen
cell
phenotyp
small
subset
fulli
regener
tumor
initi
describ
myeloid
leukemia
idea
function
divid
cancer
two
distinct
popul
rel
welldifferenti
subset
limit
prolif
capac
form
bulk
tumor
phenotyp
character
diseas
second
smaller
less
differenti
subset
contain
clonogen
csc
thu
chief
translat
repercuss
csc
hypothesi
need
specif
target
therapi
selfrenew
capac
stemcel
compart
effect
interrupt
sourc
recurr
tumor
sensit
convent
therapeut
approach
possess
multipledrug
resist
addit
properti
normal
stem
cell
contribut
longev
permit
surviv
toxic
insult
includ
mani
drug
current
use
treat
cancer
often
mediat
overexpress
adenosin
triphosphatebind
cassett
abc
transport
efflux
drug
cell
conserv
csc
like
caus
chemoresist
absenc
specif
surfac
antigen
properti
use
surrog
marker
identifi
stem
progenitor
cell
normal
tissu
includ
lung
similarli
popul
characterist
stemprogenitor
cell
also
differenti
identifi
basi
surviv
lunginjuri
model
initi
effort
identifi
airway
epitheli
stem
cell
summar
elsewher
kim
et
al
expand
earlier
studi
describ
rare
popul
bronchioalveolar
stem
cell
basc
adult
mice
initi
identifi
express
alveolar
epitheli
type
ii
cell
marker
surfact
protein
c
spc
bronchiolar
epitheli
clara
cell
marker
clara
cell
secretori
protein
ccsp
approach
prompt
part
observ
almost
cell
present
epithelium
smaller
distal
airway
earli
embryon
lung
develop
express
marker
clara
neuroendocrin
ne
cell
basc
found
restrict
bronchioalveolar
duct
junction
badj
margin
region
termin
bronchial
alveolar
epithelium
anoth
put
stemcel
nich
previous
identifi
contain
variant
clara
cell
inher
resist
naphthaleneinduc
airway
injuri
capac
contribut
subsequ
distal
airway
epitheli
repair
basc
demonstr
similar
resist
naphthaleneinduc
toxic
increas
number
period
bronchiolar
epithelium
repair
addit
intracellular
protein
spc
ccsp
basc
also
found
coexpress
antigen
establish
surfac
marker
stemcel
popul
mous
tissu
exclud
endotheli
hematopoiet
cell
viabl
basc
abl
isol
flow
cytometri
carri
multipl
passag
vitro
distinct
cultur
condit
purifi
basc
could
induc
either
expand
maintain
undifferenti
state
spcpositiveccspposit
give
rise
progeni
clara
cell
spcnegativeccspposit
spcpositiveccspneg
phenotyp
connect
basc
core
stemcel
properti
selfrenew
multipot
differenti
ultim
demonstr
stemcel
pedigre
still
remain
perform
vivo
recent
anoth
put
lung
stemcel
popul
identifi
cytokeratinposit
epitheli
coloni
aris
vitro
cultur
mous
primari
neonat
whole
lung
cell
serumfre
condit
coloni
ccspposit
differ
basc
virtu
neg
express
spc
addit
epitheli
coloni
also
express
two
marker
selfrenew
pluripot
embryon
stem
cell
brdu
pulsechas
experi
perform
neonat
mice
local
small
popul
slowcycl
cell
epitheli
layer
badj
consid
similar
two
put
lung
stemcel
popul
remain
possibl
basc
descend
neonat
lung
cell
multilineag
differenti
capac
individu
coloni
demonstr
transfer
individu
primari
coloni
cultur
dish
coat
collagen
seem
result
sequenti
differenti
process
character
initi
loss
stem
ie
protein
subsequ
matur
cell
phenotyp
spcposit
turn
gener
popul
result
partli
emul
earli
studi
cell
proffer
put
stemprogenitor
popul
respons
expans
appar
role
repair
bleomycininduc
ablat
airway
epitheli
cell
sinc
presenc
cell
assess
multipl
passag
either
primari
differenti
cultur
condit
employ
articl
preclud
assess
selfrenew
capac
put
stemcel
popul
interestingli
author
also
report
posit
epitheli
coloni
permiss
infect
variant
coronaviru
respons
sever
acut
respiratori
distress
commonli
call
sar
suggest
sever
diseas
may
result
loss
put
stemcel
compart
prevent
replac
special
lung
epitheli
cell
also
damag
viru
three
separ
studi
publish
homeostat
regul
basc
compart
link
express
sever
wellcharacter
tumor
suppressor
gene
wide
express
member
mitogenactiv
protein
kinas
mapk
famili
believ
regul
differenti
prolifer
cell
varieti
differ
mammalian
tissu
compel
evid
indic
play
key
role
divis
differenti
lung
epithelium
stemprogenitor
cell
comparison
adult
mice
heterozyg
positiveneg
homozyg
negativeneg
condit
knockout
allel
reveal
lung
latter
possess
hyperprolif
alveolar
epithelium
associ
greatli
elev
number
spcposit
cell
exhibit
lack
differenti
marker
knockout
mice
eventu
develop
respiratori
problem
die
prematur
mani
spcposit
cell
identifi
cellcyclearrest
immatur
popul
howev
costain
ccsp
also
reveal
expand
basc
subset
within
popul
whose
nich
longer
restrict
discret
badj
region
describ
previous
higher
proport
basc
isol
ex
vivo
lung
exhibit
activ
cellcycl
profil
mice
divid
rapidli
vitro
intensifi
contrast
basc
cultur
differentiationpermiss
condit
retain
spcposit
ccspposit
phenotyp
instead
differenti
spcposit
ccspposit
progeni
basc
could
persuad
behav
like
counterpart
vitro
treatment
inhibitor
associ
increas
epiderm
growth
factor
receptor
decreas
protein
level
respect
unsurprisingli
level
downstream
target
low
lung
transcript
factor
necessari
differenti
stem
cell
matur
lung
progeni
perhap
explain
poor
differenti
capac
basc
lung
similarli
establish
role
inhibit
activ
seem
respons
regul
epiderm
growth
factor
receptor
level
lung
might
help
explain
enhanc
prolifer
basc
mice
cyclindepend
kinas
cdk
play
key
role
regul
cell
cycl
integr
variou
signal
pathway
g
cellcycl
control
neg
regul
via
bind
member
famili
includ
inde
recogn
limit
selfrenew
capac
hematopoiet
stem
cell
role
seem
extend
basc
expand
spcpositiveccspposit
popul
observ
badj
lung
young
mice
nevertheless
surround
lung
architectur
seem
affect
similar
expans
basc
describ
lung
mice
bronchioalveolar
epitheliumspecif
null
mutat
phosphat
tensin
homolog
pten
key
regul
cell
divis
whose
absenc
associ
stemprogenitorcel
expans
number
tissu
tumor
suppressor
mutat
high
frequenc
larg
number
cancer
interestingli
basc
hyperplasia
associ
dramat
increas
express
sonic
hedgehog
shh
lung
molecul
requir
branch
morphogenesi
embryon
develop
promot
stemcel
selfrenew
number
tissu
hedgehog
pathway
discuss
detail
later
herein
doubleposit
spcpositiveccspposit
phenotyp
use
identifi
basc
first
describ
precursor
lesion
mous
model
adenocarcinoma
use
induc
allel
oncogen
kra
promot
cell
prolifer
compar
control
number
basc
expand
lung
mice
kra
activ
krasposit
bore
direct
correl
accompani
tumor
burden
henc
expans
basc
pool
airway
injuri
kra
activ
increas
tumor
size
number
model
similarli
basc
mice
also
sensit
krasinduc
lung
tumor
permit
earlier
induct
faster
progress
adenocarcinoma
find
accompani
observ
human
lung
tumor
express
lower
level
found
normal
lung
tissu
adenocarcinoma
contain
popul
consist
presenc
cell
seem
basc
express
activ
krasposit
mutat
retain
capac
differenti
similar
normal
counterpart
conclus
support
vitro
studi
relat
model
basc
expans
gener
mice
collabor
model
creat
aggress
heterogen
tumor
respect
model
alon
gene
encod
menin
tumor
suppressor
regul
cellcycl
progress
similarli
initi
mild
bronchioalveolar
hyperplasia
associ
earli
expans
basc
ptennul
mice
progress
spontan
lung
adenocarcinoma
moreov
ptennul
mice
suscept
chemicallyinduc
carcinogenesi
find
particularli
relev
recent
studi
demonstr
decreas
pten
express
human
nsclc
mostli
respons
epigenet
mechan
like
promot
methyl
yet
illustr
basc
lung
cancer
precursor
report
mice
modifi
gene
ckneg
knock
mice
cdkdepend
tumor
suppressor
activ
elimin
reveal
cdkindepend
oncogen
function
result
hyperplasia
tumorigenesi
multipl
organ
lung
initi
manifest
expans
basc
badj
later
throughout
bronchioalveolar
epithelium
increas
age
mice
progress
hyperplasia
dysplasia
develop
adenoma
final
overt
tumor
featur
adenocarcinoma
addit
bolster
hypothesi
lung
stemprogenitor
cell
target
tumor
initi
sustain
tumor
throughout
exist
studi
support
assert
expans
stemprogenitor
cell
alon
suffici
tumorigenesi
requir
least
one
genet
epigenet
event
furthermor
would
seem
genet
insult
assum
varieti
differ
form
interest
learn
whether
mous
model
lung
cancer
featur
cooper
earli
expans
basc
would
particularli
benefici
know
whether
basc
contribut
develop
tumor
subtyp
adenocarcinoma
condit
knockout
model
sclc
tumor
contain
marker
ne
differenti
report
gener
normal
lung
basc
presenc
clonogen
popul
cell
human
lung
cancer
first
describ
year
ago
clinic
specimen
adenocarcinoma
sclc
patient
contain
small
popul
cell
abl
form
coloni
soft
agar
clone
assay
individuallyselect
soft
agar
coloni
inject
intracrani
athym
nude
mice
abl
gener
tumor
featur
characterist
origin
patient
specimen
thu
support
exist
csc
popul
malign
small
number
sidepopul
sp
cell
identifi
efflux
hoechst
abc
transport
shown
possess
stemcel
characterist
sp
cell
recent
identifi
nsclc
clinic
sampl
cell
line
latter
express
elev
transcript
sever
abc
transport
associ
enhanc
resist
number
commonli
use
chemotherapeut
agent
compar
nonsp
cell
consist
belief
csc
immort
larg
quiescent
popul
sp
cell
also
contain
elev
mrna
level
cellular
senesc
inhibitor
telomeras
decreas
mrna
level
prolifer
marker
respect
vitro
purifi
sp
cell
demonstr
higher
potenti
invas
abl
gener
sp
nonsp
subset
result
cultur
resembl
origin
presort
cell
line
vivo
sp
cell
enrich
tumoriniti
capac
rel
nonsp
popul
requir
substanti
smaller
inoculum
gener
tumor
xenograft
nonobes
diabeticsever
combin
immunodefici
mice
implic
cancer
treatment
consider
effort
expend
search
robust
marker
csc
particularli
express
extracellularli
independ
function
stemcel
assay
identif
purif
paramount
accur
delin
mechan
respons
transform
normal
lung
cell
csc
attempt
identifi
phenotyp
marker
hoechst
dyeexclud
compart
describ
human
nsclc
unsuccess
given
addit
stain
nestin
fail
differenti
sp
nonsp
popul
human
sclc
cell
line
small
popul
urokinasetyp
plasminogen
activ
upar
posit
cell
identifi
subset
demonstr
enhanc
clonogen
activ
vitro
presenc
uparposit
uparneg
cell
result
coloni
suggest
multilineag
potenti
put
stem
cell
character
greater
detail
purifi
uparneg
cell
sclc
line
demonstr
littl
clonogen
activ
upar
link
regul
cell
adhes
migrat
elev
level
associ
poor
clinic
outcom
varieti
tumor
put
csc
marker
describ
malign
includ
acut
myeloid
leukemia
breast
prostat
brain
reflect
express
normal
tissu
counterpart
unfortun
identif
human
basc
counterpart
might
repres
import
first
step
may
difficult
virtu
fact
two
surfac
marker
use
defin
mous
basc
known
human
homolog
stain
correspond
put
sp
stem
cell
report
nsclc
howev
recent
report
describ
rare
popul
cell
normal
mous
lung
like
basc
undergo
signific
expans
regener
naphthaleneinjur
airway
freshli
dissoci
human
sclc
nsclc
tumor
contain
similar
subset
cell
abl
gener
longterm
lung
tumor
sphere
vitro
could
differenti
preferenti
form
tumor
vivo
chemoresist
tumor
sphere
associ
express
abc
transport
respons
sp
phenotyp
well
embryon
stemcel
marker
nanog
despit
common
express
differ
subtyp
lung
cancer
remain
confirm
whether
singl
normal
lung
stemprogenitor
phenotyp
suffici
defin
csc
case
multipl
origin
indic
idea
embryon
develop
program
play
key
role
lung
tumorigenesi
support
recent
studi
molecular
signatur
differ
human
lung
cancer
subtyp
compar
chang
express
profil
murin
ortholog
differ
stage
mous
lung
develop
unsurprisingli
normal
human
lung
sampl
similar
late
mous
lung
develop
stage
place
sampl
three
human
lung
cancer
subtyp
along
timelin
aggress
malign
sclc
appear
earliest
follow
squamou
carcinoma
adenocarcinoma
reflect
increas
surviv
rate
put
anoth
way
earlier
stage
mous
lung
develop
patient
lung
cancer
resembl
shorter
surviv
time
year
ago
rudolf
virchow
publish
theori
omni
cellula
e
cellula
everi
cell
origin
anoth
exist
cell
like
propos
cancer
aris
embryoniclik
cell
view
undergon
reviv
csc
theori
grow
evid
abnorm
activ
embryon
pattern
pathway
notch
hedgehog
respons
expans
malign
transform
normal
stem
cell
repres
earli
event
tumorigenesi
pathway
import
regul
cell
fate
decis
develop
lung
contribut
malign
aris
organ
discuss
one
potenti
outcom
celltocel
interact
mediat
notch
famili
receptor
relat
binari
cell
fate
decis
notch
activ
favor
one
fate
anoth
may
repres
choic
daughter
cell
one
two
new
fate
altern
adopt
new
fate
versu
retain
origin
statu
thu
critic
notch
function
develop
homeostasi
mainten
stemcel
viabil
via
asymmetr
cell
divis
demonstr
stem
cell
bone
marrow
brain
intestin
crypt
breast
epithelium
simplifi
overview
notch
signal
receptor
one
cell
activ
ligand
adjoin
cell
lead
ultim
activ
transcript
target
princip
set
inhibitori
basic
helixloophelix
transcript
factor
includ
turn
transcript
repressor
protein
obstruct
positivelyact
basic
helixloophelix
member
knockout
mous
studi
demonstr
requir
notch
signal
lung
develop
elev
notch
ligand
receptor
level
demonstr
nsclc
line
notch
signal
also
seem
among
key
downstream
effector
oncogen
ra
commonli
present
malign
relev
notch
signal
nsclc
pathogenesi
highlight
data
demonstr
increas
apoptosi
serum
depend
reduc
vitro
vivo
nsclc
tumor
growth
respons
blockad
pathway
activ
use
inhibitor
paradox
overexpress
activ
inhibit
vitro
clonogen
vivo
tumorigen
adenocarcinoma
line
underscor
complex
notch
pathway
vari
role
may
play
differ
lung
tumor
subtyp
ordinarili
block
transcript
human
achaetescut
highli
express
sclc
tumor
characterist
ne
featur
lung
knockout
mice
markedli
increas
ne
differenti
commensur
decreas
clara
cell
notch
receptor
express
rare
seen
sclc
overexpress
activ
notch
receptor
inhibit
sclc
growth
activ
signal
produc
antitumor
effect
anoth
neuroendocrin
tumor
pulmonari
carcinoid
associ
reduc
level
human
achaetescut
protein
henc
hypothesi
seem
defect
notch
pathway
facilit
mainten
primit
ne
phenotyp
hedgehog
pathway
shown
essenti
normal
mammalian
develop
describ
simpli
signal
via
pathway
mammal
initi
bind
secret
morphogen
shh
ihh
dhh
receptor
patch
ptch
reliev
repress
smoothen
smo
ultim
manifest
regul
gli
transcript
factor
downstream
target
gene
hedgehoginteract
protein
shown
attenu
hedgehog
signal
via
direct
bind
hedgehog
ligand
therebi
enabl
differenti
respons
otherwis
compet
popul
cell
appar
hedgehog
signal
import
earli
lung
format
epithelialmesenchym
tissu
interact
control
branch
develop
mous
lung
bud
shh
express
highest
level
although
low
level
declin
toward
birth
observ
throughout
epithelium
ptch
three
gli
express
adjac
lung
mesenchym
level
reflect
shh
express
shhnull
mice
exhibit
seriou
foregut
defect
includ
incomplet
separ
respiratori
digest
system
appear
two
small
hypoblast
lung
bud
contain
saclik
structur
airway
branch
convers
overexpress
shh
control
spc
promot
result
absenc
function
alveoli
hyperprolifer
epitheli
mesenchym
lung
cell
adult
constitut
hedgehog
signal
seem
restrict
small
number
cell
persist
basal
layer
bronchial
epithelium
low
level
airway
regener
induc
naphthalen
injuri
result
expans
intraepitheli
cell
popul
activ
hedgehog
signal
pathway
reactiv
preced
expans
normal
rare
airway
ne
popul
consid
potenti
progenitor
epitheli
regener
use
confoc
immunofluoresc
similar
cluster
epitheli
cell
express
ptch
ne
marker
cgrp
observ
embryon
mous
airway
immedi
adjac
cell
express
shh
unlik
nsclc
line
growth
sclc
tumor
primit
featur
pulmonari
neuroendocrin
differenti
retent
compon
hedgehog
signal
pathway
inhibit
steroid
alkaloid
hedgehog
antagonist
cyclopamin
togeth
data
suggest
normal
airway
epitheli
progenitor
cell
assum
ne
fate
respons
shh
signal
provid
adjac
epitheli
cell
sclc
may
result
signal
unregul
tenet
current
guid
research
laboratori
predic
exist
small
chemoresist
popul
clonogen
cell
within
sclc
depend
aberr
activ
hedgehog
signal
preserv
csc
sourc
malign
suscept
elimin
control
use
hedgehog
pathway
antagonist
absenc
wellaccept
stemcel
marker
sclc
initi
investig
idea
multipl
myeloma
mm
malign
welldefin
stemcel
compart
phenotyp
distinct
differenti
plasma
cell
patholog
defin
diseas
model
show
hedgehog
pathway
activ
markedli
concentr
within
mmcsc
compart
respons
pathway
modul
hedgehog
pathway
blockad
markedli
inhibit
clonal
expans
accompani
termin
differenti
purifi
mmcsc
littl
effect
malign
plasma
cell
growth
treatment
hedgehog
ligand
contrast
promot
expans
mm
stem
cell
without
differenti
similar
result
recent
describ
glioblastoma
preliminari
studi
use
aldefluor
reagent
system
identifi
small
popul
sever
sclc
cell
line
highlevel
aldehyd
dehydrogenas
aldh
activ
function
properti
stem
cell
clonogen
purifi
aldhhigh
cell
vitro
assay
superior
unsort
sclc
sampl
inhibit
hedgehog
antagonist
unpublish
data
express
identifi
marker
selfrenew
mammari
stem
cell
broad
differenti
potenti
normal
malign
tissu
moreov
retrospect
analysi
breast
carcinoma
tissu
microarray
reveal
posit
aldh
correl
poor
prognosi
similarli
immunohistochem
analysi
shown
elev
express
level
two
aldh
isozym
sever
nsclc
subtyp
compar
control
lung
tissu
fact
even
nonneoplast
pneumocyt
cigarett
smoke
alon
seem
suffici
elev
aldh
express
pursu
number
approach
prospect
identifi
surfac
marker
put
lung
csc
assist
us
demonstr
signific
overlap
clonogen
hedgehog
pathway
activ
chemoresist
popul
within
sclc
interestingli
exposur
cigarett
smoke
vitro
human
bronchial
epitheli
cell
acquir
abil
form
carcinoma
athym
nude
mice
directli
associ
hedgehog
pathway
activ
therapeut
target
embryon
signal
pathway
present
new
paradigm
pharmaceut
develop
approach
need
take
consider
minor
contribut
target
cell
total
tumor
burden
develop
appropri
assay
true
drug
efficaci
measur
